BIOMAT Database Logo BIOMAT Database Logo

Medical & surgical approaches to pulmonary hypertension. 1997

V V McLaughlin, and S Rich
Rush Heart Institute Center for Pulmonary Heart Disease, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.

When no other explanation for pulmonary hypertension can be found, it is referred to as primary pulmonary hypertension (PPH). Causes of pulmonary hypertension, with a special focus on PPH, as well as recent advances in both its medical and surgical treatment of pulmonary hypertension are reviewed.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D016041 Heart-Lung Transplantation The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another. Grafting, Heart-Lung,Transplantation, Heart-Lung,Grafting, Heart Lung,Graftings, Heart-Lung,Heart Lung Transplantation,Heart-Lung Grafting,Heart-Lung Graftings,Heart-Lung Transplantations,Transplantation, Heart Lung,Transplantations, Heart-Lung

Related Publications

V V McLaughlin, and S Rich
Investigational approaches to pulmonary hypertension.
January 1991, Toxicologic pathology,
V V McLaughlin, and S Rich
New approaches to pulmonary hypertension.
March 2001, Hospital practice (1995),
V V McLaughlin, and S Rich
New surgical approaches to portal hypertension.
January 1972, Progress in liver diseases,
V V McLaughlin, and S Rich
Medical and non-medical approaches to renovascular hypertension.
March 1997, Cardiologia (Rome, Italy),
V V McLaughlin, and S Rich
Primary pulmonary hypertension: diagnosis, medical and surgical treatment.
May 1990, Respiratory medicine,
V V McLaughlin, and S Rich
[Pulmonary arterial hypertension: medical treatment and surgical indications].
November 1995, Presse medicale (Paris, France : 1983),
V V McLaughlin, and S Rich
Medical and surgical treatment options for pulmonary hypertension.
March 1998, The American journal of the medical sciences,
V V McLaughlin, and S Rich
Modern Surgical Approaches to Pulmonary Hydatidosis.
August 2025, The American journal of tropical medicine and hygiene,
V V McLaughlin, and S Rich
Primary pulmonary hypertension: new approaches to therapy.
November 1980, American heart journal,
V V McLaughlin, and S Rich
[Pulmonary arterial hypertension: changing approaches to management].
January 2011, Kardiologiia,
Copied contents to your clipboard!